Touchstone TMS

Touchstone TMS in Lakewood, Washington is a specialty provider of FDA-approved psychiatric therapies for treatment-resistant depression, offering both Spravato esketamine and TMS for patients who have not achieved remission on medications alone. Spravato is an esketamine nasal spray used alongside an oral antidepressant, targeting the NMDA receptor to work differently than traditional antidepressants.

In clinical studies, patients taking Spravato with an oral antidepressant saw greater reductions in depression symptoms at four weeks than those on placebo. Both Spravato and TMS relieve symptoms in roughly 70% of treatment-resistant cases.

While the focus is major depressive disorder, these therapies can also help with anxiety, PTSD, and OCD. The insurance team handles the full prior-authorization process on each patient's behalf.